ClinicalTrials.Veeva

Menu

Relevance of Reversible Causes During OHCA (Rebecca Study) (REBECCA)

Medical University of Vienna logo

Medical University of Vienna

Status

Enrolling

Conditions

Cardiopulmonary Arrest
Out-Of-Hospital Cardiac Arrest

Treatments

Diagnostic Test: Checklist for evaluation of reversible causes

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05784480
Rebecca Vienna

Details and patient eligibility

About

Management of the reversible causes in cardiac arrest is fundamental for successful treatment of out-of-hospital cardiac arrests. Point-of-care diagnostics as prehospital emergency ultrasound, blood gas analysis and toxicological screening support the diagnostic process of evaluating potential reversible causes. Digital tools provide support of a structured approach. This study aims to evaluate the frequency of reversible causes during OHCA as well as specific interventions due to these findings. Furthermore, CPR performance (hands-off, ROSC, 30-day mortality) and cognitive load of the prehospital emergency physician will be investigated. In total 100 patients with OHCA will be included in this study. Identification of reversible causes will be performed upon a structured protocol using an interactive checklist. Cognitive load of emergency physician as well as CPR parameter (frequency of reversible causes, hands-off, ROSC, 30-day mortality) will be analysed.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with prehospital cardiac arrest, where POCUS, blood gas analysis as well as screening for intoxication can integrated in ALS rhythm without delay of life-saving treatment or transportation will be included.

Exclusion criteria

  • Patients will be excluded under the age of 18, or if POCUS, blood gas analysis will lead to a delay of live-saving treatment or transportation. Furthermore, pregnant patients will be excluded.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

100 participants in 1 patient group

Evaluation of reversible causes using digital checklist and diagnostic support
Other group
Treatment:
Diagnostic Test: Checklist for evaluation of reversible causes

Trial contacts and locations

2

Loading...

Central trial contact

Andreas Schmid, Dr.; Christina Hafner, DDr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems